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The protein harakiri (Hrk) is a pro-apoptotic BH3-only protein which belongs to the Bcl-2 family. Hrk appears associated to the mitochondrial
outer membrane, apparently by a putative transmembrane domain, where it exerts its function. In this work we have identified a 27mer peptide
supposed to be the putative membrane domain of the protein at the C-terminal region, and used infrared and fluorescence spectroscopies to study
its secondary structure as well as to characterize its effect on the physical properties of phospholipid model membranes. The results presented here
showed that the C-terminal region of Hrk adopts a predominantly α-helical structure whose proportion and destabilization capability varied
depending on phospholipid composition. Moreover it was found that the orientation of the α-helical component of this C-terminal Hrk peptide was
nearly perpendicular to the plane of the membrane. These results indicate that this domain is able of inserting into membranes, where it adopts a
transmembrane α-helical structure as well as it considerably perturbs the physical properties of the membrane.
© 2007 Elsevier B.V. All rights reserved.Keywords: Harakiri; Fluorescence; Infrared; Lipid–protein interaction1. Introduction
The human protein harakiri (Hrk) and its murine ortholog DP5
belong to the Bcl-2 family of proteins [1,2], whose members
share some of the four homologous domains of protein bcl-2
(BH1 to BH4). Of these domains, the BH3 one is closely linkedAbbreviations: 5NS, 5-Doxyl-stearic acid; 16NS, 16-Doxyl-stearic acid;
ANTS, 8-Aminonaphtalene-1,3,5-trisulfonic acid; ATR, attenuated total reflec-
tion; BPS, Bovine phosphatidylserine; DMPA, 1,2-Dimyristoyl-sn-glyceropho-
sphatidic acid; DMPC, 1,2-Dimyristoyl-sn-glycerophosphatidylcholine;
DMPCd, 1,2-Dimyristoyl-d54-sn-glycero-3-phosphatidylcholine; DMPG, 1,2-
Dimyristoyl-sn-glycerophosphatidylglycerol; DMPS, 1,2-Dimyristoyl-sn-gly-
cero-3-phosphatidylserine; DPH, 1,6-Diphenyl-1,3,5-hexatriene; DPX, p-
Xylene-bis-pyridiniumbromide; EPA, Egg yolk L-α-phosphatidic acid; EPC,
Egg yolk L-α-phosphatidylcholine; EPG, Egg yolk L-α-phosphatidylglycerol;
IR, Fourier transform infrared spectroscopy; LUV, Large unilamellar vesicles;
MLV, Multilamellar vesicles; OMM, outer mitochondrial membrane; BPI,
Bovine phosphatidylinositol.; POPE, 1-Palmitoyl-2-oleoyl-sn-glycero-3-phos-
phoethanolamine; Tm, Temperature of the gel-to-liquid crystalline phase
transition; TMA-DPH, 1-(4-Trimethylammoniumphenyl)-6-phenyl-1,3,5-hexa-
triene; TMCL, 1,1′,2,2′-Tetramyristoyl-Cardiolipin
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doi:10.1016/j.bbamem.2007.02.023to the pro-apoptotic activity and the BH3-only proteins, including
Bik/Nbk, Bim, Bad, Bid, Puma, Noxa, Blk, Bod, Bnip3 as well
as Hrk/DP5, have pro-apoptotic functions [see ref. [3] for a recent
review]. The BH3-only proteins participate in vital biological
processes, and their absence contributes to neoplasia and auto-
immunity [4]. Both proteins Hrk and DP5 heterodimerize with
either Bcl-2 or Bcl-XL in vitro; the deletion of the BH3 domain
of Hrk abolishes its capacity to interact with Bcl-2 and Bcl-XL as
well as its apoptotic activity, in a similar way to other proteins
from the same family like Bax or Bak [5–7]. In addition, some
members from this family, including Hrk, possess a C-terminal
domain that has a high hydrophobic character and it is thought to
be associated with biological membranes and responsible for its
cellular location [1]. Hrk appears localized to membranes of
intracellular organelles in a pattern similar to the previously
reported for Bcl-2 and Bcl-XL [1,8].
The Hrk expression is relatively restricted to brain and
lymphoid tissues but has been also demonstrated in pancreas,
liver, lung and kidney as well [1,2], suggesting that Hrk may
have a specific role in initiating neuronal and hematopoietic cell
apoptosis under physiological and pathological conditions.
However, the mechanism of Hrk-mediated apoptosis is still
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hrk gene is under the control of the c-Jun N-terminal kinase
pathway [9] as well as the transcriptional repressor DREAM
[10] and that apoptosis by Hrk requires the expression of Bax
[9]. Moreover, it has been observed that Hrk appears located in
mitochondria associated with p32 suggesting that physical and
functional interaction with p32 might have a crucial role in Hrk-
mediated apoptosis [11]. It should be recalled that mitochon-
drial membrane permeabilization, as induced by Bax and Bak
oligomer formation, provokes the release of pro-apoptotic pro-
teins, such as cytochrome c, but the mechanism which underlies
this process is largely unknown [3]. In this context it could be
suggested that the putative transmembrane segment of Hrk
might be involved in the interaction of Hrk with the mito-
chondrial membrane [12,13].
It has been previously observed that the phospholipid
composition of the membrane, its physical state and the
distribution of its components could affect the interaction of
the BCL-2 family proteins with cellular membranes and
therefore its apoptotic activity [14]. The existence of a
hydrophobic transmembrane domain in Hrk suggests that this
protein is an integral protein; however the mechanism of Hrk
apoptotic activity is unknown. There are some evidences from
other proteins that the membrane domain is necessary for its pro-
apoptotic activity, as for example in the protein Bax, whose C-
terminal domain regulates its cellular location and cell death
activity [15], whereas its deletion abrogates its ability to insert
itself into mitochondria during apoptosis [16]. Furthermore, it
has been recently observed that the expression of DP5/Hrk is
increased in oligodendrocytes by amyloid beta peptide and
ceramide [17], which might suggest a significant role of
membrane components and interactions on apoptosis mediated
by Hrk/DP5. Elucidating the nature of the interactions between
phospholipids and membrane proteins and peptides is important
for the understanding of the structure and function of membrane
proteins and to clarify the specific roles of these specific types of
phospholipids in biological membranes. In this work we report
our results on the determination of the secondary structure and
the interaction with model membranes of the putative trans-
membrane domain of Hrk, the structural changes which take
place in both the peptide and phospholipid molecules induced by
membrane binding and its orientation with respect to the lipid
bilayer.
2. Materials and methods
2.1. Materials
The synthetic peptide encompassing residues 65–91 of Hrk (65LPTYWP-
WLCAAAQVAALAAWLLGRRNL91) was synthesized as a C-terminal amide
on an automatic multiple synthesizer (Genemed Synthesis, San Francisco, CA).
The peptide was purified by reverse-phase HPLC to better than 95% of purity,
and its composition and molecular mass were confirmed by amino acid analysis
and mass spectroscopy. Since trifluoroacetate has a strong infrared absorbance at
approximately 1673 cm−1, which interferes with the characterization of the
peptide Amide I band of the peptide, located between 1700 and 1600 cm−1 and
composed mainly (approx. 80%) by the C_O stretching vibration of the
peptidic bond [18], residual trifluoroacetic acid used both in the peptide
synthesis and in the HPLC mobile phase was removed by several lyophilization/solubilization cycles in 10 mM HCl [19]. 1,2-Dimyristoyl-sn-glyceropho-
sphatidylcholine (DMPC), 1,2-dimyristoyl-d54-sn-glycero-3-phosphatidylcho-
line (DMPCd), 1,2-dimyristoyl-sn-glycerophosphatidic acid (DMPA), egg yolk
L-α-phosphatidylcholine (EPC), egg yolk phosphatidylglycerol (EPG), egg yolk
L-α-phosphatidic Acid (EPA), brain L-α-phosphatidylserine (BPS), 1,1′,2,2′-
Tetramyristoyl-cardiolipin (TMCL), 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phoethanolamine (POPE), 1,2-dimyristoyl-sn-glycerophosphatidylglycerol
(DMPG), 1,2-dimyristoyl-sn-glycero-3-phosphatidylserine (DMPS) and bovine
phosphatidylinositol were obtained from Avanti Polar Lipids (Birmingham,
AL). Deuterium oxide (99.9% by atom), 5-doxyl-stearic acid (5NS), 16-doxyl-
stearic acid (16NS), HEPES, Triton X-100, NaCl and EDTA were purchased
from Sigma (Sigma-Aldrich, Madrid, Spain). 1,6-Diphenyl-1,3,5-hexatriene
(DPH), 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-
DPH), 8-aminonaphtalene-1,3,5-trisulfonic acid (ANTS), and p-xylene-bis-
pyridiniumbromide (DPX) were obtained fromMolecular Probes (Eugene, OR).
All other chemicals were commercial samples of the highest purity available
(Sigma-Aldrich, Madrid, ES). Water was twice distilled and deionised in a
Millipore system (Millipore, Madrid, Spain).
2.2. Hydrophobic moments, hydrophobicity, and interfaciality
The hydrophobic moment calculations were carried out according to
Eisengberg et al. [20,21], and the scale for the calculating hydrophobic moments
was taken from Engelman et al. [22]. Hydrophobicity and interfacial values, i.e.,
whole residue scales for the transfer of an amino acid of an unfolded chain into
the membrane hydrocarbon palisade and the membrane interface respectively,
were obtained from http://blanco.biomol.uci.edu/hydrophobicity_scales.html
[23,24]. Two-dimensional plots of the hydrophobic moments were obtained
using a window of seven amino-acids, taking into consideration the arrangement
of the amino-acids in the space and assuming an α-helical structure [25]. Each
specific value in the two-dimensional plot represents the mean of the values
pertaining to the hydrophobic moment, hydrophobicity, and interfaciality of the
amino acid position and its neighbours. Positive values correspond to positive
bilayer-to-water transfer free energy values, and therefore, the higher the value,
the greater probability to interact with the membrane surface and/or the
hydrophobic fence [23,24].
2.3. Sample preparation
For IR spectroscopy, aliquots containing the appropriate amount of lipid in
chloroform/methanol (2:1, v/v) were placed in a test tube containing 200 μg of
dried lyophilized peptide to obtain a final lipid/peptide mole ratio of 15:1. After
vortexing, the solvents were removed by evaporation under a stream of O2-free
nitrogen, and finally, traces of solvents were eliminated under vacuum in the
dark for more than 3 h. The samples were hydrated in 200 μl of either D2O or
H2O buffer containing 20 mM HEPES, 50 mM NaCl, 0.1 mM EDTA, pH 7.4
and incubated at 10 °C above the phase transition temperature (Tm) of the
phospholipid mixture with intermittent vortexing for 45 min to hydrate the
samples and obtain multilamellar vesicles (MLV). The samples were frozen and
thawed five times to ensure complete homogenization and maximization of
peptide/lipid contacts with occasional vortexing. Finally the suspensions were
centrifuged at 15000 rpm at 25 °C for 15 min to remove the possibly peptide
unbound to the membranes. The pellet was resuspended in 25 μl of either D2O or
H2O buffer and incubated for 45 min at 10 °C above the Tm of the lipid mixture,
unless stated otherwise.
Large unilamellar vesicles (LUV) with a mean diameter of 90 nm were used
to study vesicle leakage. They were prepared from multilamellar vesicles in the
absence of peptide by the extrusion method [26] using polycarbonate filters with
a pore size of 0.1 μm (Nuclepore Corp., Cambridge, CA, USA) using 10 mM
HEPES, 200 mM NaCl, pH 7.4, buffer. At high concentrations (i.e., inside LUV
liposomes), ANTS and DPX form a low fluorescence complex. Breakdown of
the vesicle membrane leads to leakage, complex decomposition, and high ANTS
fluorescence. Thus, buffer used for preparing LUV liposomes for assays of
vesicle leakage contained in addition 25 mM ANTS and 90 mM DPX. Non-
encapsulated fluorescent probes were separated from the vesicle suspension
through a Sephadex G-75 filtration column (Pharmacia, Uppsala, Sweden) eluted
at room temperature with 10 mMHEPES, 130mMNaCl, 0.1 mMEDTA, pH 7.4
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oneswere used, because of the great variability in the basal fluorescence using the
last ones. For fluorescence anisotropy experiments, MLV samples were prepared
as above and aliquots of stock solutions of either DPH or TMA-DPH in N,N′-
dimethylformamide (2×10−4 M) were directly added into the sample dispersion
to obtain a probe/lipid molar ratio of 1/750 (total phospholipid concentration was
0.49mM). In order to incorporate the probes the samples were incubated at 10 °C
above the phase transition temperature Tm of the phospholipid mixture for 60min
in the case of DPH and 30 min in the case of TMA-DPH. In all cases the peptide/
lipid ratio was 15:1. The phospholipid mixture resembling the outer mito-
chondrial membrane (OMM) contained EPC/EPE/BPI/TMCL/BPS at a molar
percentage of 48:31:10:9.5:1.5 for leakage experiments whereas it contained
DMPC/POPE/BPI/TMCL/DMPS at the same molar relationship for the
quenching and infrared studies [27]. The phospholipid and peptide concentration
were measured by methods described previously [28,29].
2.4. Fluorescence spectroscopy
Leakage and anisotropy assays were carried out using a Varian Cary Eclipse
fluorescence spectrophotometer with a Xe flash lamp equippedwith an automatic
polarizer accessory. Temperatures were controlled by a Peltier-thermostatted
multicell holder. Typical spectra bandwidths were 5 nm for excitation and 5 nm
for emission. The excitation and emission wavelengths were 360/362 and 425/
450 nm when observing the DPH and TMA-DPH fluorescence, respectively.
Fluorescence anisotropies were determined according to,
r ¼ IVV  GIVH
IVV þ 2GIVH ð1Þ
where IVVand IVH are the fluorescence intensities and the subscripts indicate the
vertical (V) or horizontal (H) orientations of the excitation and emission Glan–
Thompson polarizers [30]. The instrumental factor G (G= IHV/IHH) was
determined by measuring the polarized components of fluorescence of the
protein or probes with horizontally polarized excitation. Quenching assays were
carried out using a SLM 8000C spectrofluorimeter with a 400 W Xe Lamp,
double emission monochromator, and Glan–Thompson polarizers. Correction of
excitation spectra was performed by using a rhodamine B solution and a standard
lamp. Typical spectra bandwidths were 4 nm for excitation and 2 nm for
emission. All fluorescence studies were carried using 5 mm×5 mm quartz
cuvettes. All the data were corrected for background intensities and progressive
dilution.
Leakage was assayed by treating the probe-loaded liposomes (final lipid
concentration, 0.1 mM) with appropriate amounts of peptide in a fluorimeter
cuvette. Changes in fluorescence intensity were recorded at excitation and
emission wavelengths of 350 and 510 nm, respectively. One hundred percent
release was achieved by adding Triton X-100 to the cuvette at a final
concentration of 0.1% (wt/wt). Leakage was quantified on a percent basis
according to the following equation,
% Release ¼ Ff  F0
F100  F0
 
ð2Þ
with Ff being the equilibrium value of fluorescence after the peptide addition, F0
being the initial fluorescence of the vesicle suspension, and F100 being the
fluorescence value after the addition of Triton X-100.
For acrylamide quenching assays, aliquots from a 4 M solution of the water-
soluble quencher were added to the solution-containing peptide in the presence
and absence of liposomes at a final acrylamide concentration of 0.25 M. The
results obtained were corrected for dilution and the scatter contribution was
derived from acrylamide titration of a vesicle blank. Acrylamide quenching data
were analyzed by the Stern–Volmer equation [31],
F0=F ¼ 1þ Ksv½Q ð3Þ
where F0 and F represent the fluorescence intensities in the absence and the
presence of the quencher [Q], respectively, and Ksv is the Stern–Volmer
quenching constant, which is a measure of the accessibility of Trp to acrylamide.
Quenching studies with lipophylic probes were performed by successive
addition of small amounts of 5NS or 16NS probe in ethanol to the samples of thepeptide incubated with LUV. The final concentration of ethanol was kept below
2.5% (v/v) to avoid any significant bilayer alterations. After each addition an
incubation period of 15 min was kept before the measurement. The effective
quencher concentration in the membrane [Q]L was calculated using the
following relationship [32],
½QL ¼ ½QT 1
KPQgL½L
1 gL½L þ KPQgL½L
 
KPQ
1 gL½L
ð4Þ
where γL is the phospholipid molar volume, [Q]T is the total quencher
concentration, [L] is the lipid molar concentration and Kp,Q is the partition
coefficient of the quencher. The KPQ values for 5NS and 16NS were as reported
previously [33]. The fluorescence data were analyzed using a direct fit according
to the following relationship [32].
I0
I
¼ 1þ KSV½QLð1þ KSV½QLÞð1 fBÞ þ fB
ð5Þ
where I0 is the fluorescence intensity in the absence of quencher, Ksv is the
Stern–Volmer quenching constant, and fB= I0,B/I0, where I0,B is the fluorescence
intensity of the fluorophore population accessible to the quencher. The
excitation and emission wavelengths were 292 and 347 nm, respectively.
The partitioning of the peptide into the phospholipid bilayer was monitored
by the fluorescence enhancement of tryptophan. Fluorescence was recorded at
excitation and emission wavelengths of 292 and 347 nm, respectively using 8-
nm bandwidths on an SLM 8000C spectrofluorimeter. Measurements were
carried out in 20 mM HEPES, 50 mM NaCl, 0.1 mM EDTA, pH 7.4. Peptides
were added from stock solutions in DMSO to 300 μl of buffer in a fixed LUV
lipid concentration (1 mM) and mixed. Intensity values (I) were adjusted for
lipid scattering and normalized to that of the peptide in buffer (Io). Partitioning
coefficients were obtained by means of the equation [34],
I
Io
¼ 1þ KP½L½W  þ KP½L
 
 Imax
I0
 
 1
 
ð6Þ
where I and I0 are the final intensity and the initial respectively, Imax is a variable
value for the fluorescence enhancement at complete partitioning determined by
fitting the equation to the experimental data, [L] is the concentration of lipid, [W]
is the concentration of water and Kp is the mole fraction partition coefficient that
represents the amount of peptide in the bilayer as a fraction of the total amount of
peptide present in the system.
2.5. Infrared spectroscopy
Approximately 25 μl of a pelleted sample in D2O were placed between two
CaF2 windows separated by either 50-μm thick Teflon spacers in a liquid
demountable cell (Harrick, Ossining, NY). The spectra were obtained in a
Bruker IFS55 spectrometer using a deuterated triglycine sulfate detector. Each
spectrum was obtained by collecting 200 interferograms with a nominal
resolution of 2 cm−1, transformed using triangular apodization and, in order to
average background spectra between sample spectra over the same time period,
a sample shuttle accessory was used to obtain sample and background spectra.
The spectrometer was continuously purged with dry air at a dew point of −40 °C
in order to remove atmospheric water vapour from the bands of interest. All
samples were equilibrated at the lowest temperature for 20 min before
acquisition. An external bath circulator, connected to the infrared spectrometer,
controlled the sample temperature. For temperature studies, samples were
scanned using 2 °C intervals and a 2-min delay between each consecutive scan.
Subtraction of buffer spectra taken at the same temperature as the samples
was performed interactively using either GRAMS/32 or Spectra-Calc (Galactic
Industries, Salem, MA) as described previously [35,36]. Frequencies at the
centre of gravity, when necessary, were measured by taking the top 10 points of
each specific band and fitted to a Gaussian band. Band-narrowing strategies
were applied in order to resolve the component bands in the amide I′ region.
Second-derivative spectra were calculated over a 15 data point range. Fourier
self-deconvolution [37] of the subtracted spectra was carried out using a
Lorentzian shape and a triangular apodization with a resolution enhancement
parameter, K, of 2.2, which is lower than log(signal/noise) [38] and a full width
at half-height of 18 cm−1. These parameters assume that the spectra were not
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Protein secondary structure elements were quantified from curve-fitting analysis
by band decomposition of the original amide I′ band after spectral smoothing
using the same software stated above [35,36]. Briefly, for each component, three
parameters were considered: band position, band height, and band width. The
number and position of component bands were obtained through deconvolution,
and in decomposing the amide I′ band, Gaussian components were used. The
curve-fitting procedure was accomplished in two steps: in the first one, band
position was fixed, allowing width and heights to approach final values, and in
the second one, band positions were left to change. When necessary, these two
steps were repeated. Band decomposition was performed using SpectraCalc
(Galactic Industries, Salem, MA). The fitting result was evaluated visually by
overlapping the reconstituted overall curve on the original spectrum and by
examining the residual obtained by subtracting the fitting from the original
curve. The procedure gave differences of less than 2% in band areas after the
artificial spectra were submitted to the curve-fitting procedure. The frequency
positions of the band centres were independently evaluated by second derivative
procedures, being always very close to the positions found by deconvolution.
Samples for ATR measurements were prepared as described previously. The
sample was oriented by depositing on a ZnSe ATR crystal. These membrane
peptide films were dried in a N2 atmosphere for 1 h under vacuum and
rehydrated afterwards [39]. ATR-IR spectra were obtained by using an infrared
beam polarized with a KRS-5 polarizer (Specac, Orpington, UK) and a
horizontal ATR holder (Spectra-Tech., Shelton, CT). The ATR crystal was cut
with an incident angle of 45°. Under these conditions, the infrared beam travels
along the crystal plate about 35 total internal reflections before being directed to
the detector. Each sample spectrum was ratioed with a single-beam background
spectrum obtained with the polarized set at 0° (A||) or at 90° (A⊥) using an empty
ATR crystal. Evaluation of the dichroic ratio
RATR ¼ Ajj
A8
ð7Þ
was estimated from the infrared ATR spectra. RATR is the ratio between the
integrated absorbance of the infrared band measured with parallel and
perpendicular polarization of the incident light (A|| and A⊥, respectively). The
ATR crystal was always washed with an alkaline detergent, rinsed with distilled
water and washed with chloroform and methanol. The angles have been
calculated using a value between 22° and 39° for the angle between the C_O
dipole and the helix axis [40].
3. Results
Hydrophobic moments measure the periodicity of residue
distribution along a secondary structure element [20,21]. The
preferential orientation of the hydrophobic moments towards
one face of that element has been proposed to favour
hydrophobic interactions between proteins and/or between
proteins and membranes. In order to detect surfaces along the
Hrk sequence which might be identified as membrane
partitioning and/or membrane interacting zones, we have
plotted the average surface hydrophobic moments, hydropho-
bicity and interfaciality versus the full Hrk amino acid
sequence, supposing an α-helical structure along the whole
sequence (Fig. 1A). Analyzing the results it is readily evident
the existence of one region, at the C-terminal part of the protein,
presenting high positive values which would match the
proposed transmembrane domain of the Hrk protein. The
inspection of the hydrophobicity and interfaciality values along
the Hrk sequence (Fig. 1B) reveals that this region posses a zone
with high interfaciality values and a relative high content on
aromatic residues followed immediately by a hydrophobic one,
characteristic of transmembrane regions [25,41]. This region,
corresponding to residues 65–91 of the Hrk protein sequence, isthe one which has been selected in the present work as the
putative transmembrane segment of the protein (Fig. 1C).
Once the sequence was selected, the ability of the
corresponding Hrk peptide to interact with membranes was
determined from fluorescence studies of its three Trp residues in
the presence of phospholipid model membranes at different lipid/
peptide ratios [36]. The Trp fluorescence intensity of the Hrk
peptide increased upon increasing the lipid/peptide ratio,
indicating a significant change on the environment of the Trp
moiety of the peptide [36]. The change on the Trp fluorescence of
the peptide has allowed us to obtain its partition coefficient, Kp.
Kp values of 1.94±0.11·10
6 M−1 for EPA, 1.86±0.16·106 M−1
for the OMM complex lipid mixture, 1.63±0.09·106 M−1 for
EPG and 5.98±0.13·105 M−1 for EPC were obtained, indicating
that the peptide was bound to the membrane surface with high
affinity. Similar Kp values have been found for other peptides in
the presence of model membranes [30,32,36,42]. These results
were further corroborated by the displacement in the emission
frequency maximum of Trp. In aqueous solution the peptide had
an emission maximum at 339 nm when excited at the absorbance
maximum, whereas in the presence of increasing concentrations
of liposomes the emission maximum of the Trp was displaced to
332 nm, implying that Trp sensed a low-polarity environment,
upon interaction with the membrane. In order to asses the
interaction of the Hrk peptide with the membrane, the release of
fluorescent probes trapped inside LUVs was monitored at
increasing concentrations of peptide (Fig. 2). LUVs were
composed of unsaturated phospholipids, i.e., EPC, EPA, EPG
and OMM, instead of saturated ones to avoid the great variability
in the basal fluorescence and the rapid release of the probes even
in the absence of the peptide as reported previously [36]. In the
presence of EPC there were significant leakage values, since at a
lipid-to-peptide ratio of 250:1 a leakage of 100% was observed;
even at a lipid-to-peptide ratio of 500:1 a leakage of about 80%
was observed (Fig. 2). Lower but significant values of leakage
were also observed for the complex phospholipid mixture OMM,
since at a lipid-to-peptide ratio of 100:1 a leakage of about 95%
was observed. Much lower leakage values were found in the
presence of both EPA and EPG, since leakage values of about 80
and 35% were observed at a lipid-to-peptide ratio of 5:1 (Fig. 2).
These results would indicate that the peptide affects more
significantly membranes containing zwitterionic phospholipids
rather than those containing negatively-charged ones (it should be
recalled that themajor phospholipid in theOMMmixture is EPC).
The effect of acrylamide on the Trp fluorescence of the Hrk
peptide is presented in Fig. 3A. The studies were performed with
the peptide in free solution and in the presence of liposomes
composed of EPC, EPG, EPA and the OMM synthetic mixture at
a lipid/peptide ratio of 15:1. Linear Stern–Volmer plots are
indicative of all Trp residues being fairly accessible to
acrylamide. The Stern–Volmer constant value, Ksv, for the
peptide in solution was found to be 12.74 M−1 whereas it was
2.56, 4.19, 4.26 and 6.97 M−1 for DMPG, DMPA, DMPC and
the OMM complex mixture, respectively. Moreover, according
to our data static and dynamic quenching does not co-exist. In all
cases, the quenching of the peptide Trp residues showed
acrylamide dependent concentration behaviour. In free solution
Fig. 1. (A) Representation of the full Hrk sequence assuming it forms an α-helical wheel on a two-dimensional array. Each value in the two-dimensional plot represents
the mean of the values pertaining to the hydrophobic moment (HM), hydrophobicity (H) and interfaciality (I) of the aminoacid at that position plus those of its
neighbours (window, seven aminoacids). (B) Analysis of the hydrophobicity (––) and interfaciality (- - -) distribution according to the scales of Wimley and White
[23,24] using a window of 11 amino acids along the Hrk sequence without any assumption about secondary structure. Only positive bilayer-to-water transfer free
energy values are depicted in (A) and (B). The sequence and location of the Hrk peptide sequence studied in this work (dotted boxes in A and B) is indicated in (C).
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allowing to a more efficient quenching. However, in the
presence of the phospholipid membranes, the quenching effect
was smaller, suggesting that the Trp residues were less
accessible to the quencher. The transverse location (penetration)
of the Hrk peptide into the lipid bilayer was further investigated
by monitoring the relative quenching of the fluorescence of the
Trp residues when the peptide was incorporated in the fluid
phase of EPC, EPG, EPA and OMM by the lipophilic spin
probes 5-NS and 16-NS. These two derivatised fatty acids differ
in the position of the quencher moiety along the hydrocarbon
chain and let us to establish the depth of the fluorophore in the
membrane by comparing the quenching results obtained witheach of them. The addition of any of the two nitroxide quenchers
resulted in a decrease of the peptide fluorescence. The Stern–
Volmer plots of the fluorescence intensity changes were linear
(see Fig. 3B). It can be seen that 16-NS, which has its nitroxide
group at carbon-16, quenches the Hrk peptide fluorescence less
efficiently than 5-NS, pointing out that some or all of the Hrk
peptide Trp residues are located in the phospholipid membrane
in a shallow position at the water/membrane interface. The
Stern–Volmer constant value, Ksv, was found to be 4.5±0.3,
6.3±0.4, 10.6±0.8 and 15.4±0.7 M−1 for 5NS and 4.4±0.4,
4.5±0.7, 5.9±0.3 and 2.3±0.5 M−1 for 16NS in samples
containing the Hrk peptide and DMPA, DMPC, DMPG and the
OMM complex mixture, respectively. Interestingly, the ob-
Fig. 2. Effect of the Hrk peptide on the release of fluorescent probes
encapsulated in LUVs for different lipid compositions. Leakage data for LUV
composed of EPA (■), EPC (●), EPG (□) and lipid mixture resembling the
OMM (○) at 25 °C and different peptide-to-lipid ratios as indicated.
Experimental conditions are described in the text. Vertical bars indicate standard
deviations of the mean for quadruplicate samples.
Fig. 3. (A) Acrylamide quenching studies of the Hrk peptide in solution (□) and
in the presence of vesicles composed of DMPC (○), DMPG (▴), DMPA (■)
and the OMM lipid mixture (▵). (B) 5NS (closed symbols) and 16NS (open
symbols) quenching studies of the Hrk peptide in the presence of vesicles
composed of DMPC (●, ○), DMPG (■,□), DMPA (♦, ⋄) and OMM (▴, ▵).
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vesicles than for the EPC and EPG containing ones (Fig. 3B).
The effect of the Hrk peptide on the structural and
thermotropic properties of phospholipid membranes was
investigated by measuring the steady-state fluorescence aniso-
tropy of the fluorescent probes DPH and TMA-DPH incorpo-
rated into DMPC, DMPG, DMPA and OMM membranes as a
function of temperature (Fig. 4). Using both types of fluorescent
probes it is possible to analyze the peptide effect on the
structural and thermotropic properties along the full length of
the membrane, since DPH displays a central location in the
bilayer [43] and TMA-DPH is located at the lipid/water
interface [44]. The Hrk peptide decreased the cooperativity of
the transition as well as it induced an increase of the anisotropy
for both types of probes below and above the gel to liquid-
crystalline transition Tm of DMPC, suggesting that the peptide
was able to decrease the mobility of the phospholipid acyl
chains when compared to the pure phospholipid (Fig. 4A).
When the Hrk peptide was incorporated into DMPG and DMPA
membranes a decrease in the cooperativity of the mixtures was
also observed as it was observed previously for DMPC (Fig. 4B
and C, respectively). In contrast to DMPC membranes, the
anisotropy for both DMPG and DMPA decreased below the Tm
but increased above it. These differences could suggest that the
difference in charge between DPMA/DMPG and DMPC could
affect, although slightly, the effects of the peptide incorporation
into the membrane. When the Hrk peptide was incorporated into
the OMM mixture, neither the cooperativity nor the anisotropy
below and above the Tm of the mixture was significantly
affected (Fig. 4D). Taking into account all these data, it could be
suggested that the Hrk peptide could be inserted to some extent
into the membrane palisade [30]. It should be stressed that no
quenching of the probes by the peptide were observed in this
concentration range. In this way, this variation of anisotropy
cannot be ascribed to a shorter probe lifetime.The infrared spectrum of the Amide I′ region of the fully
hydrated peptide in D2O buffer plus 10% TFE at 20 °C and pH
7.4 is shown in Fig. 5A. The spectrum is formed by different
underlying components that give place to a broad and
asymmetric band with a maximum at about 1651 cm−1. The
maximum of the band did not change significantly upon
increasing the temperature (not shown), suggesting a high
degree of conformational stability of the peptide in solution. The
band envelope of the Amide I′ band of the peptide bound to
DMPC and DMPA model membranes was not significantly
different to that found for the pure peptide in solution, since, the
frequencies at the maximum of the band appeared at about
1650 cm−1 in both cases (Fig. 5B and C). As it was found for the
peptide in solution, the maximum of the band did not change
significantly upon increasing the temperature in the presence of
the model membranes (not shown), indicating again a high
degree of conformational stability. We have applied self-
deconvolution and derivative methods to the original Amide I′
band to observe its underlying components [42]. For the peptide
in solution, we have identified different component bands at
frequencies of about 1680, 1670, 1660, 1652, 1641, and
Fig. 4. Anisotropy values of TMA-DPH (■, □) and DPH (●, ○) fluorescent probes in membranes composed of DMPC (A), DMPG (B), DMPA (C) and the OMM
lipid mixture (D) in the presence (■, ●) and in the absence (□, ○ ) of the Hrk peptide.
1665A. Bernabeu et al. / Biochimica et Biophysica Acta 1768 (2007) 1659–16701630 cm−1, being the 1652 cm−1 band the main one (Fig. 5A).
The results of the decomposition of the Amide I′ of the Hrk
peptide in the presence of DMPC and DMPA are shown in Fig.
5B and C. The number and frequencies of the Amide I′
component bands for these samples were identical to those found
for the peptide in solution, but their intensity varied. To assign
the component bands to specific structural features and estimate
the percentage of each component, we have decomposed the
Amide I′ infrared as described previously [36] and the results are
presented in Table 1. Bands below 1620 cm−1 are outside the
range of frequencies usually observed for the secondary
structure elements of proteins so they were not considered in
the determination of the total area of the Amide I´ band
[36,42,45,46]. The most significant difference between the
secondary structure of the Hrk peptide in solution and in the
presence of DMPC is that in the last case, a decrease in the α-
helix content and a concomitant increase of random coil of aboutFig. 5. Amide I′ band decomposition of the Hrk peptide spectra in the presence of 10%
taken at Tm −10 °C. The component bands, the original envelope and the difference10% was observed (Table 1). However, in the presence of
DMPG, it was observed an increase of 10% for random coil and
a decrease in turns when compared with the peptide in solution.
In the presence of the OMM complex mixture, the secondary
structure component which significantly increased was the one
corresponding to β-sheet. Similarly interesting was the change
in the secondary structure for the peptide in the model mixtures
containing either DMPA or TMCL, since an increase of about
10% was observed for the α-helix content (Table 1). These
results suggest then that the secondary structure of the Hrk
peptide was affected by phospholipid composition.
The orientation of the Hrk peptide was investigated by ATR-
IR in the presence of two different membrane compositions,
namely DMPC and DMPG as it has been described previously
[14]. In all the cases the spectra obtained showed positive
deviation in the Amide I´ band (1700–1600 cm−1) indicating an
orientation of the Amide I´ dipole parallel to the lipid acylof TFE (A) and in the presence of DMPC (B) and DMPA (C). The spectra were
between the fitted curve and the original spectrum are shown.
Table 1
Comparison of the secondary structure of the Hrk peptide as determined by infrared spectroscopy in solution and in the presence of phospholipid mixtures as indicated
α-Helix / 310-Helix
1650–1670 cm−1 (%)
β-Sheet
1625–1640 cm−1 (%)
Random
1641–1649 cm−1 (%)
β-Turn
1670–1690 cm−1 (%)
Hrk (20 °C) 43 20 24 13
+DMPC (Tm −10 °C) 32 20 33 15
+DMPG (Tm −10 °C) 41 20 34 5
+OMM (Tm −10 °C) 42 30 20 8
+DMPA (Tm −10 °C) 53 15 24 8
+DMPC/DMPA (Tm −10 °C) 55 16 23 6
+DMPC/TMCL (Tm −10 °C) 51 18 13 18
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(about 32% α-helix) was found to be 8–35° whereas
incorporated in DMPG membranes (about 41% α-helix) was
0–21°. It should be noted, as it has been noted before [14], that
this technique does not discriminate between a fixed uniaxial
orientation and the mean of two or more populations with
different orientations. However the positive Amide I´ deviation
in the difference spectra and the tilt angles calculated indicated
the transmembrane character of the peptide as described for
other Bcl-2 family proteins [14,47].
Although it has been shown that the incorporation of
transmembrane peptides in the phospholipid palisade of the
membrane can affect not only the phospholipid chain order but
also inter-chain coupling, a shift in the frequency of the CH2
symmetric stretching band is a reliable index of the phase
behaviour of phospholipid dispersions [48]. The temperature
dependence of the CH2 symmetric frequency of pure DMPC is
shown in Fig. 6A, where a highly cooperative change at
approximately 23 °C was observed, corresponding to the gel-to-
liquid crystalline phase transition, Tm, of the phospholipid. In the
presence of the Hrk peptide, the cooperativity of the gel-to-liquid
crystalline phase transition of DMPC was reduced, it was shifted
slightly to lower temperatures and the frequency of the CH2
symmetric frequency increased slightly below but not above the
Tm when compared with the pure phospholipid. In the case of
DMPA a highly cooperative change corresponding to the main
transition Tm of the phospholipid was observed at approximately
47 °C (Fig. 6B). The presence of the Hrk peptide induced a shift of
the Tm to lower temperatures as well as a slight decrease in the
cooperativity of the transition. Significantly, the frequency of the
CH2 symmetric frequency decreased above but not below the Tm
when compared with the pure phospholipid, indicating that the
peptide induced an increase in the proportion of trans isomers
when compared with the pure phospholipid. When the Hrk
peptide was incorporated in DMPG, a decrease in the coopera-
tivity of the transition was observed (Fig. 6C). Significantly, the
frequency of the CH2 symmetric frequency increased and
decreased below and above the Tm, respectively, when compared
with the pure phospholipid, indicating that the proportion of trans
isomers was lower and higher below and above the Tm. In the
presence of the OMM complex mixture a slight increase in the
cooperativity was observed (Fig. 6D) at the same time that a
decrease in the frequencywas observed at all temperatures. Except
for the lipid composition resembling the outer mitochondrial
membrane (OMM) in all the other cases the Hrk peptide decreasedthe cooperativity of the phospholipid main transition, suggesting
that it was capable to interact depth with the bilayer affecting the
acyl chains package. The peptide also altered the proportion of
trans-gauche conformers in all the cases, suggesting that the
peptide was able of altering the order degree of the bilayer. We
have also studied the effect of the Hrk peptide in phospholipid
binary mixtures where the acyl chains of one phospholipid was
perdeuterated (DMPCd), and the other, either DMPA or TMCL,
was not, so that it was possible to detect independent changes in
each phospholipid type (data not shown for briefness). However,
we did not observe any phase separation between the zwitterionic
and negatively-charged phospholipids, suggesting that the Hrk
peptide did not display any significant lipid affinity.
In order to better characterize the phases of both DMPA and
DMPGwehave also examined the temperature dependence of the
stretching vibration bands arising from the C_O ester of the
phospholipids. Pure DMPC showed a broad C_O carbonyl band
which presented, after deconvolution, two components at
1742 cm−1 and 1727 cm−1 (not shown for briefness) attributed
to dehydrated and hydrated C_O groups, respectively; the
frequencies of these two components were not affected by
temperature, but their relative intensities changed as reported for
other phospholipids [36].Whereas below the phase transition, the
1742 cm−1 component had a higher intensity than the 1727 cm−1
component, at temperatures above the phase transition just the
opposite was observed. The frequency at the maximum of the
C_O vibration band for both pure DMPC and DMPG in the
presence of the Hrk peptide displayed a large cooperative
transition corresponding to the gel-to-liquid crystalline phase
transition of the phospholipid, but the intensity of the dehydrated
C_O group in the presence of the peptides was higher than in its
absence at temperatures below and above the Tm (Fig. 6E).
Differently to what was observed for DMPC, the Hrk peptide
induced a increase in the intensity of the hydrated C_O group in
samples containing either DMPA or DMPG at all temperatures,
significantly more below the Tm than above it (Fig. 6F and G). In
the case of the OMM complex mixture, apart from the difference
observed in the cooperativity of the main transition commented
above, no significant differences were found below and above Tm
(Fig. 6H).
4. Discussion
Hrk, as it has been observed in other BCL-2 family proteins,
possess a putative transmembrane fragment responsible for its
Fig. 6. Temperature dependency of the phospholipid CH2 (A–D) and C_O ester group (E–H) stretching frequency values of (A, E) DMPC, (B, F) DMPA, (C, G)
DMPG, (D, H) OMM in the absence (○) and in the presence (●) of the Hrk peptide.
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protein sequence and found a region at the C-terminal part of the
protein (residues 65–91) which presents a high interfacial andhydrophobic character and therefore a tendency to interact
significantly with membranes. Understanding the characteristic
features that determine the specificity and stability of membrano-
1668 A. Bernabeu et al. / Biochimica et Biophysica Acta 1768 (2007) 1659–1670tropic regions of proteins is required for the understanding of their
mechanism. In this study we have focused on the study of the
structure and interaction of this specific region of Hrk with model
membranes since it might be fundamental for its mechanism of
action, and found that the phospholipid composition in the
membrane modulates its structural properties.
Since the Hrk protein is thought to be incorporated in the
outer mitochondrial membrane [11] apart from using model
membranes composed of only one synthetic phospholipid, we
have used vesicles resembling the phospholipid composition of
the outer mitochondrial membrane. The results obtained using
different biophysical techniques confirmed that the Hrk peptide
was capable to incorporate very efficiently into the membranes
independently on the phospholipid composition. The binding to
the surface and the modulation of the phospholipid biophysical
properties which take place when the peptide is bound to the
membrane, i.e., partitioning into the membrane surface and
perturbation of the bilayer architecture, could be related to the
conformational changes which might occur during the pro-
apoptotic activity of Hrk. Although it should not be ruled out the
possibility of pore formation [3], the interaction of the peptide
with the surface of the membrane could effectively reduce the
head-group area of the phospholipids and promote the
formation of non-bilayer phases which would lead to the
rupture of the mitochondrial membrane [49]. In the presence of
membranes the peptide induces a decrease on the cooperativity
of the phase transition of the phospholipid mixtures as well as a
change on the proportion of the trans/gauche conformers
suggesting that the peptide is capable of altering the membrane
properties even at the middle of the palisade structure of the
membrane. The peptide was also capable of altering the
liposomes stability causing the release of fluorescent probes.
However this effect was dependent on the lipid composition and
on the lipid/peptide molar ratio, being the highest effect
observed in EPC liposomes. Since this phospholipid is not
capable of establishing electrostatic interactions in the bilayer
surface, the effect observed should be due primarily to
hydrophobic interactions within the bilayer but not to the
specific charge of the phospholipid headgroups.
The infrared spectra of the Amide I′ region of the fully
hydrated peptide indicated a high stability of its conformation,
even at high temperatures, where the α-helix structure
predominated (Table 1). The α-helix structure content found
in this peptide is similar to that found for other transmembrane
domains in other BCL-2 family proteins [50–52]. However we
have observed differences on the proportion of the different
secondary elements when the peptide was incorporated into
membranes of different phospholipid composition. Whereas the
α-helix content was similar in solution and in the presence of
DMPG and the OMM complex mixture, it decreased about 10%
in the presence of DMPC and it increased in a similar quantity in
the presence of DMPA and TMCL. With respect the β-sheet
content, it increased about 10% in the presence of OMM,
whereas random increased for DMPC and DMPG but decreased
for TMCL (Table 1). These data would suggest that the presence
of different phospholipid headgroups would modulate the
secondary structure of the peptide as it has been suggested forother peptides [14,30,36,42,50]. In this context it is interesting
to note that the α-helix component of the Hrk peptide should
bear a near perpendicular orientation with respect to the plane of
the membrane. It has been shown that proteins which appear
associated with the outer mitochondrial membrane or the
endoplasmic reticulum employ the transmembrane domain as a
membrane target sequence [53]. In fact, some authors proposed
a hydrophobic sequence flanked by at least two basic residues in
both extremes as a possible mitochondrial target sequence
independently of the length of the hydrophobic sequence [54–
56]. The Hrk region selected for this work displays these
characteristics, but it does not present any phospholipid
specificity which could suggest that the lipid specificity, if it
exists, could be present in other segments of the protein. For
example in Bcl-2 it was observed the existence of a sequence
previous to the target one which would serve to reinforce the
mitochondrial location [56]. Therefore, in physiological condi-
tions the specific interaction of the Hrk protein with the OMM
would be regulated by the transmembrane domain but also by
other different regions of the protein and/or specific interactions
with other proteins like p32.
In summary, our results show that the C-terminal domain of
Hrk adopts a predominantly α-helical structure when inserted
into membranes and alters the physical properties of the
phospholipid bilayer inducing a very efficient release of trapped
probes. This domain, located on the C-terminal region of the
protein, would be able to constitute, in physiological conditions,
the anchorage domain of the protein to the outer mitochondrial
membrane, it would be structurally constituted by a transmem-
brane α-helix whose orientation and secondary structure would
come determined by phospholipid composition.
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